. Show Affiliations »
Abstract
Mesh: See more » Anti-HIV Agents/administration & dosageClinical Trials, Phase II as TopicControlled Clinical Trials as TopicDose-Response Relationship, DrugDrug Administration ScheduleEnfuvirtideHIV Envelope Protein gp41/administration & dosageHIV Infections/drug therapyHumansPatient SelectionPeptide Fragments/administration & dosageUnited States
Substances: See more » Anti-HIV AgentsHIV Envelope Protein gp41Peptide FragmentsEnfuvirtide
Year: 1999 PMID: 10813040
Source DB: PubMed Journal: AIDS Patient Care STDS ISSN: 1087-2914 Impact factor: 5.078